SCRIPGEN

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES INCLUDING, BUT NOT LIMITED TO BACTERIAL, FUNGAL, AND VIRAL INFECTIONS; PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISEASES INCLUDING, BUT NOT LIMITED TO SCHIZOPHRENIA, DEPRESSION, ALZHEIMER'S, MIGRAINES, ANXIETY, AND PAIN; CARDIOVASCULAR SYSTEM DISEASES INCLUDING, BUT NOT LIMITED TO ATHEROSCLEROSIS, HYPERTENSION, STROKE, AND CONGESTIVE HEART FAILURE; DIGESTIVE ORGANS DISEASES INCLUDING, BUT NOT LIMITED TO GASTRIC ULCERS, AND ESOPHAGEAL REFLUX; MUSCULOSKETAL SYSTEM DISEASES INCLUDING, BUT NOT LIMITED TO ARTHRITIS; METABOLIC DISEASES INCLUDING, BUT NOT LIMITED TO OBESITY AND DIABETES; RESPIRATORY SYSTEM DISEASES INCLUDING, BUT NOT LIMITED TO ASTHMA, PNEUMONIA AND TUBERCULOSIS; UROGENITAL ORGANS DISEASES INCLUDING, BUT NOT LIMITED TO CYSTITIS, YEAST INFECTIONS, AND HEPATITIS; NEOPLASTIC DISEASES INCLUDING, BUT NOT LIMITED TO CANCER OF THE BREAST, LUNG, PROSTATE, AND COLON; SKIN DISORDERS INCLUDING, BUT NOT LIMITED TO PSORIASIS AND HERPES; IMMUNE SYSTEM DISEASES INCLUDING, BUT NOT LIMITED TO HIV, RHEUMATOID ARTHRITIS, AND IMMUNE SUPPRESSION AGENTS FOR ORGAN TRANSPLANTS; HEMATOPOIETIC DISEASES INCLUDING, BUT NOT LIMITED TO SICKLE CELL ANEMIA, THALASSEMIA, HEMOSTASIS AND OTHER BLOOD DISORDERS; GENETIC DISEASES INCLUDING, BUT NOT LIMITED TO DOWN'S SYNDROME, HUNTINGTON'S CHOREA, AND CYSTIC FIBROSIS; ENDOCRINE SYSTEM DISEASES INCLUDING, BUT NOT LIMITED TO SYMPTOMS OF MENOPAUSE; REPRODUCTIVE SYSTEM DISEASES INCLUDING, BUT NOT LIMITED TO FERTILITY CONTROL

RESEARCH SERVICES IN THE FIELD OF BIOLOGY AND MEDICINE